Stefan Buck
Impact in
-
- HER2/EGFR in Cancer Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- RNA and protein synthesis mechanisms 4
- Oncology 10
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Co-authors
- Gerhard Maas (9 shared papers)Neva Caliskan (6 shared papers)Matthias M. Zimmer (3 shared papers)Redmond P. Smyth (4 shared papers)José Baselga (4 shared papers)Tove Tuntland (1 shared paper)Cristina Saura (3 shared papers)Rowan Stringer (1 shared paper)
- Journals
- Cancer Research (3 papers)ESMO Open (2 papers)Nature Communications (1 paper)Clinical Cancer Research (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Stefan Buck
30 papers receiving 452 citations
Peers
Comparison fields: 5 of 69
- Oncology 110
- Genetics 37
- Molecular Biology 195
- Organic Chemistry 82
- Pharmaceutical Science 14
Countries citing papers authored by Stefan Buck
This map shows the geographic impact of Stefan Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Buck more than expected).
Fields of papers citing papers by Stefan Buck
This network shows the impact of papers produced by Stefan Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Buck. The network helps show where Stefan Buck may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Buck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 110 | |
| 2 | 2021 | 66 | |
| 3 | 2016 | 45 | |
| 4 | 2006 | 41 | |
| 5 | 2012 | 28 | |
| 6 | 2022 | 25 | |
| 7 | 2006 | 23 | |
| 8 | 2018 | 15 | |
| 9 | 2022 | 12 | |
| 10 | 2013 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2018 | 8 | |
| 13 | 2015 | 8 | |
| 14 | 2018 | 7 | |
| 15 | 2025 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2012 | 5 | |
| 18 | 2011 | 4 | |
| 19 | 2012 | 4 | |
| 20 | 2022 | 4 |
About Stefan Buck
Stefan Buck is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Inorganic Chemistry, having authored 30 papers that have together received 459 indexed citations. Recurring topics across this work include Cyclopropane Reaction Mechanisms (6 papers), Advanced Breast Cancer Therapies (5 papers), Asymmetric Hydrogenation and Catalysis (5 papers), Cancer Treatment and Pharmacology (4 papers), RNA and protein synthesis mechanisms (4 papers), Viral Infections and Immunology Research (4 papers), Influenza Virus Research Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (110 citations), Genetics (37 citations), Molecular Biology (195 citations), Organic Chemistry (82 citations) and Pharmaceutical Science (14 citations). Stefan Buck has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Gerhard Maas, Neva Caliskan, Matthias M. Zimmer, Redmond P. Smyth, José Baselga, Tove Tuntland, Cristina Saura, Rowan Stringer, Nathalie Gobeau and Samit Hirawat. Their work appears in journals such as Cancer Research, ESMO Open, Nature Communications, Clinical Cancer Research and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.